Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained upregulation of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: results form tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods.
Yamagishi M, Higashikata T, Ishibashi-Ueda H, Sasaki H, Ogino H, Iihara K, Miyamoto S, Nagaya N, Tomoike H, Sakamoto A. Yamagishi M, et al. Among authors: tomoike h. Circ J. 2005 Dec;69(12):1490-5. doi: 10.1253/circj.69.1490. Circ J. 2005. PMID: 16308497 Free article.
Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method.
Higashikata T, Yamagishi M, Higashi T, Nagata I, Iihara K, Miyamoto S, Ishibashi-Ueda H, Nagaya N, Iwase T, Tomoike H, Sakamoto A. Higashikata T, et al. Among authors: tomoike h. Atherosclerosis. 2006 Mar;185(1):165-72. doi: 10.1016/j.atherosclerosis.2005.05.039. Epub 2005 Jul 21. Atherosclerosis. 2006. PMID: 16039658
Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysm.
Higashikata T, Yamagishi M, Sasaki H, Minatoya K, Ogino H, Ishibashi-Ueda H, Hao H, Nagaya N, Tomoike H, Sakamoto A. Higashikata T, et al. Among authors: tomoike h. Atherosclerosis. 2004 Dec;177(2):353-60. doi: 10.1016/j.atherosclerosis.2004.07.013. Atherosclerosis. 2004. PMID: 15530910
Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-.
Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T. Kamiya CA, et al. Among authors: tomoike h. Circ J. 2011;75(8):1975-81. doi: 10.1253/circj.cj-10-1214. Epub 2011 May 27. Circ J. 2011. PMID: 21617320 Free article. Clinical Trial.
The role of a common TNNT2 polymorphism in cardiac hypertrophy.
Komamura K, Iwai N, Kokame K, Yasumura Y, Kim J, Yamagishi M, Morisaki T, Kimura A, Tomoike H, Kitakaze M, Miyatake K. Komamura K, et al. Among authors: tomoike h. J Hum Genet. 2004;49(3):129-133. doi: 10.1007/s10038-003-0121-4. Epub 2004 Feb 24. J Hum Genet. 2004. PMID: 14986170
A novel data mining approach to the identification of effective drugs or combinations for targeted endpoints--application to chronic heart failure as a new form of evidence-based medicine.
Kim J, Washio T, Yamagishi M, Yasumura Y, Nakatani S, Hashimura K, Hanatani A, Komamura K, Miyatake K, Kitamura S, Tomoike H, Kitakaze M. Kim J, et al. Among authors: tomoike h. Cardiovasc Drugs Ther. 2004 Nov;18(6):483-9. doi: 10.1007/s10557-004-6226-y. Cardiovasc Drugs Ther. 2004. PMID: 15770436
428 results